Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Apple

Marathon Digital Holdings

Newmont Mining

Could investors turn their inflation fears into returns with these stocks?

Best Inflation Stocks To Buy Now? 4 To Know

ABM Industries

H.B. Fuller

Hormel Foods

Lowe's

Northwest Natural Gas

Stanley Black & Decker

Sysco

The 32 Dividend Kings gained 4.05% in October, underperforming the broad market.

Best Dividend Kings For November 2021

Enterprise Products Partners

AT&T

These income stocks, with yields ranging between 8% and 8.3%, have Wall Street's attention.

3 Ultra-High-Yield Dividend Stocks With 42% to 50% Upside, According to Wall Street

Amgen

Bristol-Myers

Lockheed Martin

Unum

Verizon

Looking at the market today, it's clear that while some segments and companies suffer from overvaluation, this is far from a universal state. There are massively undervalued investment opportunities, where you essentially get paid to wait for the company to appreciate.

The Best 9%-25%+ Undervalued Companies Today

Flowers Foods

Gaming and Leisure Properties

Huntington Bancshares

Kinder Morgan

LyondellBasell Industries

M.D.C. Holdings

Medical Properties Trust

NRG Energy

Omnicom Group

Sturm, Ruger & Company

Retail Opportunity Investments

Vale S.A.

Valero Energy

Williams

Exxon Mobil

May-August 2021, Kiplinger Today listed eight sets of stocks sorted as: best-buys for 2021, infrastructure-plays, value, growth, small-cap, high-yield, housing-bets, and cash-flow-gushers. Those eight "exceptional-dividend" articles revealed 86 equities, 76 paying dividends. Kiplinger article titles were, '21 Best Stocks to Buy'; '14 Best Infrastructure Stocks'; '16 Best Value'; '10 Dividends-Growth'; '6 Small-Cap'; '10 High-Yield 4% or More'; '12 Housing'; '10 Cash-Flow-Gushers.'

11 Exceptional November Dividend Buys

Atmos Energy

Colgate-Palmolive

Con Ed

Johnson & Johnson

Kimberly-Clark

Novartis

The market is up 8% in a few weeks, and the 28% overvalued S&P 500 offers near-zero inflation and risk-adjusted expected returns over the next five years. Fortunately, there are always wonderful blue-chips available at reasonable to attractive prices, even high-yield, low-volatility dividend aristocrats.

The 10 Safest High-Yield Dividend Aristocrats To Buy With The Market At Record Highs

Cronos Group

Shares of Cronos Group Inc (TSE: CRON) are up more than 20% on Monday after New Cannabis Ventures said Altria Group Inc (NYSE: MO) could buy the remaining outstanding shares of the pot producer as soon as next week. Altria already has a 45% stake in Cronos Group Altria currently has a 45% stake in […] The post Speculation: Altria could buy the balance of Cronos Group appeared first on Invezz.

Speculation: Altria could buy the balance of Cronos Group

Cronos Group Strategic Investor Altria May Be About To Buy The Balance

MPLX

ONEOK

With the stock market seemingly ripping higher every day, many investors are wondering what to do now.

Despite Massive Market Melt-Up, 4 Buy-Rated Stocks With Huge Dividends Are Still Cheap

AbbVie

Automatic Data Processing

BlackRock Taxable Municipal Bond Trust

Calamos Convertible Opportunities And Income Fund

Clorox

Digital Realty Trust

DNP Select Income Fund Inc

iShares MSCI EAFE Value ETF

Fastenal

Flaherty & Crumrine Preferred Securities Income Fund Inc

Home Depot

McDonald's

NextEra Energy

Annaly Capital

PIMCO Dynamic Credit and Mortgage Income Fund

Cohen & Steers Quality Income Realty Fund

iShares 1-3 Year Treasury Bond ETF

Columbia Seligman Premium Technology Growth Func Inc

abrdn World Healthcare Fund 

No portfolio or strategy can be perfect. But can there be a strategy that can work well in a bull market, a bear market, or a stagnant market, generate a decent income, and conserve capital, all at the same time? We also want our strategy to avoid roller-coaster rides of index investing, have low volatility and limited drawdowns in case of deep corrections.

The Near-Perfect Portfolio For The Good Times And Bad

The latest U.S. budget proposal from House Democrats reinserted the "taxable nicotine" concept but left out other tobacco tax hikes.

Altria: New U.S. Tax Proposal Would Protect Cigarettes, Buy

Bank of America

PepsiCo

Regions Financial

UnitedHealth Group

Those worried about what's going on in China right now may want to consider these seven stocks we view as relatively safe from these woes. The post 7 Safe Stocks that are Immune from China's Market Volatility appeared first on InvestorPlace.

7 Safe Stocks that are Immune from China's Market Volatility

Last Thursday, Altria Group, Inc. (NYSE:MO) suffered a 6.2% bear gap after the tobacco giant's lackluster quarterly report.

Is Altria Stock a Must-Buy for Dividend Investors?

"What would John Malone do?" faced with valuable assets, a low valuation and an aversion to paying taxes.

Altria Could Unlock Value With A Tracking Stock For BUD Shares

A whale with a lot of money to spend (and possibly insider knowledge) has taken a noticeably bearish stance on Altria Group. Looking at options history for Altria Group (NYSE:MO) we detected 12 strange trades.

What Are Whales Doing With Altria Group

Philip Morris

Philip Morris International ( PM , Financial), the non-US manufacturer and distributor of the Marlboro cigarette brand, announced in August 2021 that it would be issuing an ESG bond.[1] Yes, you read that right.

Trust Us, We're Kool: A Cautionary Tale for ESG Investors Who Actually Care

News for Altria Stock (MO)